Peter halesworth

Shares of Zhaopin Ltd (ADR) (NYSE: ZPIN), a China-based career platform business that connects users with relevant job opportunities, spiked higher by more than 7 percent after the company received a new acquisition offer. Zhaopin's CEO Evan Sheng Guo, along with a consortium of investors led by...

U.S. investors in Chinese ADR’s could be getting forced to accept low-ball buyout offers. According to a new report by Heng Ren Partners analyst Peter Halesworth, Chinese companies are squeezing out American investors by systematically buying out U.S shares at severely depressed premiums....

Shares of Sinovac Biotech Ltd. (NASDAQ: SVA) were trading up more than 13 percent in Thursday's pre-market session after the company announced it received a non-binding proposal letter from a consortium of investors to acquire the company for $7.00 per share. The consortium includes PKU V-...

The coverage of Chinese management buyout of companies listed on U.S. exchanges has been vast since last year. Joining that large list includes Chinese biotech company Sinovac Biotech Ltd. (NASDAQ: SVA). Sinovac on Monday released two subsequent 6-K. The first 6-K announces the issuance of Good...

Back in March, Benzinga covered the intrinsic value of fintech investments made by fading Chinese social media company Renren Inc (NYSE: RENN). Among Renren's many investments, its approximate 25 percent stake in SoFi looked to be the most promising, as the company was looking to IPO...

Chinese “Go-Private” deals have littered the PR feeds of investors with increased uncertainty in the global macro environment. Often times, executive management teams of these Chinese companies see value taking the company private and re-listing back in China. While nothing would look...